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 Environmental toxicants are ubiquitous throughout the environment as a result of 
human activity. Among these toxicants, environmental estrogens are a category of 
particular concern due to their environmental prevalence and potency in altering 
reproductive traits. While many studies have addressed the detrimental effects of 
environmental estrogens on both aquatic and terrestrial organisms, few have analyzed the 
potential for these compounds to alter mitochondrial function. Mitochondria are the 
primary energy-generating system for all eukaryotic life, supporting all aspects of 
development, metabolism, and growth. Each cell within the body contains many 
mitochondria which in turn contain multiple copies of their own DNA genome, 
mitochondrial DNA (mtDNA). Mutations in mtDNA are responsible for a wide range of 
human diseases such as metabolic syndromes, cancers, and obesity. Among these 
mitochondrial diseases many are characterized by increased levels of heteroplasmy, 
multiple mitochondrial DNA haplotypes within an individual. Increased heteroplasmy 
can alter normal mitochondrial function and influence disease initiation and progression.  
 To date, no studies have investigated the effects of synthetic estrogens on 
mitochondrial genome stability. Synthetic estrogens have the capacity to bind to estrogen 
receptors and initiate estrogenic responses through translocation into the mitochondrion. 
Despite our knowledge about the relationship of heteroplasmy and disease, we still do not 
have a complete grasp of the mechanisms of heteroplasmic induction. Here we report our 
analysis of the effects of 17α-ethynylestraiol (EE2) exposure in three studies to 
investigate its effect on mitochondrial genome stability. Data analysis reveals a 
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Chapter I: Overview and Background 
 Mitochondria are vital intracellular organelles, central to most eukaryotic life. 
They are best identified for their role in the production of cellular energy. This efficient 
system coordinates energy production based on the availability of organic molecules and 
oxygen to meet energy demands. They are also key to a continuum of other essential 
cellular functions. Multiple cell wide stress responses are coordinated by mitochondria 
and they play a principal role in both cellular life and cellular death. They support all 
aspects of development, metabolism, and growth and are vital in the maintenance of adult 
tissue homeostasis (Nunnari & Suomalainen, 2012; Youle et al., 2012).  
 Mitochondrial origins represent one of the earliest known symbioses occurring 
>1.5 billion years ago between a proto-mitochondrion and a host prokaryote cell(Brown, 
2008; Gray, 1999). This event marked the initiation and diversification of eukaryotic life 
itself. Over time, this symbiosis evolved into an irreversible merger of mitochondria into 
the host cytoplasmic organelle system and eukaryotes are marked by the co-occurrence of 
two complete genomes, nuclear (e.g., host) and mitochondrial in animals. Genes with 
duplicate function between symbiotic partners became redundant and as part of the 
symbiotic inclusion process, the mitochondrial genome underwent a genome reduction in 
animals either through gene transfer and/or loss of duplicate genes. This reduction in size 
has resulted in extremely compact mitochondrial genomes, particularly in vertebrates, 
with overlapping coding sequences essential to organelle function (Brown, 2008; Gray, 
Burger, & Lang, 1999; Timmis, Ayliffe, Huang, & Martin, 2004).  
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 Structurally mitochondria have two membranes, an outer and inner, required for 
normal function. The outer membrane encloses the entire organelle and contains a large 
number of membrane proteins which allow smaller molecules and ions to pass freely to 
the inner side of the outer membrane. The inner mitochondrial membrane is a highly 
convoluted structure with folded invaginations, cristae, which increases the inner 
membrane surface area. This membrane is highly impermeable and contains the 
gelatinous matrix rich in ions, proteins, and enzymes involved in cellular metabolic 
processes (e.g., tricarboxylic acid cycle). Also, embedded within the inner membrane are 
numerous protein complexes, sites of metabolic pathways (e.g., oxidative 
phosphorylation) happening entirely or in-part within the mitochondria (Gray, 1999; 
Schapira, 2006; Wallace & Fan, 2011). 
 Both the inner mitochondrial membrane and matrix are central to mitochondrial 
metabolic processes. Of these, the most important is the synthesis of adenosine 
triphosphate (ATP) through oxidative phosphorylation (OXPHOS). OXPHOS, the final 
step in aerobic cellular respiration (Figure 1) generates a net 36 ATP at a cost of 1 glucose 
molecule. Simplified, this process begins with the import of the glycolytic product 
pyruvate into the mitochondrial matrix. Pyruvate is reduced to mitochondrial acetyl 
coenzyme-A (acetyl coA), CO2 and NADH. From there, acetyl-coA enters the 
tricarboxylic acid cycle (TCA cycle, i.e., citric acid or Kreb cycle) where it’s converted to 
metabolic intermediates through a concentrated series of redox reactions, occurring 
within the mitochondrial matrix. During the TCA cycle, the reduction of organic acid 
intermediates produces excess NADH and FADH2 which are the predominant electron 
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carriers used in the electron transport chain (Wallace, Fan, & Procaccio, 2011; Wallace & 
Fan, 2011).  
 
 
Figure 1: Schematic of cellular respiration. The glycolytic product pyruvate is imported into the 
mitochondrial matrix, reduced acetyl coenzyme-A where it enters the citric acid cycle (TCA). During 
the TCA cycle, acetyl CoA produces electron carriers used in the electron transport chain (within the 
inner mitochondrial membrane), the site of oxidative phosphorylation producing a net 36 molecules of 
cellular energy, ATP. 
 The electron transport chain is composed of a series of embedded inner 
mitochondrial membrane protein complexes that work to transfer electrons with the 
concomitant extrusion of proton ions. Working as electron carriers, NADH and FADH2 
are oxidized as they supply electrons to O2. Protons are pumped out of the mitochondrial 
matrix into the intermembrane space as electrons are passed along the transport chain. 
This process creates an electrochemical gradient that results in energetically favorable 
phosphorylation of ADP and phosphate into ATP as protons flow back into the 
mitochondrial matrix (Figure 2). The highly impermeable inner mitochondrial membrane 
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is key in creating an electrochemical gradient between the matrix and intermembrane 
space (Duchen, 2004; Nunnari & Suomalainen, 2012). 
 
Figure 2: Schematic of electron transport chain showing the embedded inner mitochondrial membrane 
proteins transfer of electrons and concomitant extrusion of protons. This processes creates an 
electrochemical gradient that results in the phosphorylation of ADP and phosphate into ATP as protons 
flow back into the mitochondrial matrix (Schapira, 2006). 
 In addition, other catabolic pathways contribute to the production of ATP within 
the mitochondria through the catabolism of other macromolecules In the process of β-
oxidation, fatty acids are degraded in the mitochondria to generate acetyl-CoA units 
which feed the TCA cycle. The mitochondrial enzyme pyruvate oxaloacetate is involved 
in the conversion of metabolic intermediates involved in gluconeogenesis. Even 
ketogenic processes occur entirely within the mitochondria during periods of high β-
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oxidative activity and low TCA activity where acetyl-coA is converted to ketone bodies 
(Kroemer et al., 2012; Nunnari & Suomalainen, 2012).  
 Reactive oxygen species (ROS) are a normal byproduct of metabolic pathways 
occurring within the mitochondria with the most prominent source being cellular 
respiration. Excess production can cause oxidative stress resulting in damaged 
mitochondrial proteins, lipids, and DNA. Damaged cellular components are causal to 
metabolic dysfunction, alterations in membrane potential, and further increase the 
production of ROS. These aberrant conditions can increase ATP consumption to 
compensate for membrane potential deviations, further perpetuating adverse cellular 
conditions. Repair and quality-control mechanisms safeguard mitochondria from the 
detrimental or deleterious effects of oxidative stress. In response to genotoxic damages 
caused by ROS, mitochondria initiate some forms of DNA repair pathways similar to 
those in the nucleus (Gladyshev, 2013).  
 Normal mitochondrial activity is dependent on the functioning of over a thousand 
proteins. These proteins are encoded mostly by genes within the nuclear genome 
(nDNA); however, each individual mitochondrion contains multiple (i.e., between 5-10) 
circular genomes necessary for its function. The mitochondrial genome (mtgenome or 
mtDNA) is highly compact with no introns and very few intergenic spaces. In vertebrates, 
it ranges from 15,000-17,000 kilobases (kb) in length and encodes for 37 genes necessary 
respiratory chain activity and translation of mtDNA genes (Broughton, Milam, & Roe, 
2001; Kelly & Scarpulla, 2004). 
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 Given the central role in mitochondria in most cellular processes, impaired 
mitochondrial function is causal to a variety of diseases. These phenotypes range from 
alterations in cell function to cell death as a result of mutations in mtDNA. Mitochondrial 
disease can be heterogeneous or multisystemic, but often preferentially affects tissues or 
systems with high-energy demands including the brain, heart, muscle, digestive and 
endocrine systems. Severity of disease states is often related to mtDNA copy number 
(i.e., the proportion of mutated to wild-type mtgenomes). The mixture of mutant and 
wildtype (i.e., normal) mtDNA genomes within a single mitochondrion, cell, tissue or 
individual is termed heteroplasmy (Chan, 2006; Jayaprakash et al., 2014; Nunnari & 
Suomalainen, 2012; Wallace & Chalkia, 2016).  
 Given mitochondria’s strict pattern of maternal inheritance, heteroplasmy can 
occur from germ-line inheritance, (i.e., from oocyte cytoplasm), or arise as somatic 
mutations (Brown, 2008). If a heteroplasmic oocyte is fertilized and forms a zygote, 
during each cell division different mitochondrial genomes (i.e., heteroplasmy) can be 
randomly distributed to the daughter cells and continue to be copied during each cell 
cycle. Unequal distribution can contribute to mitochondrial disease initiation and onset. 
When mutant mtDNA is inherited through oocyte transmission, the proportion of mutated 
mtgenomes, as well as replication and distribution, is stochastic (Wallace & Fan, 2011). 
Over many cell generations, heteroplasmy can increase (i.e., higher proportions of mutant 
mtDNA) and consequently those cells undergo a decrease in the production of energy 
(Wallace & Chalkia, 2016).  
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 Somatic mutations can occur in mtDNA just as they do in nuclear DNA. 
Mitochondria have a high mutation rate as they lack protective histones like nuclear DNA 
and have only rudimentary repair mechanisms. Mitochondria undergo fission and fusion 
events as a mechanism of redistribution to meet altered energetic demands but also to 
selectively remove stressed or damaged organelles. MtDNA molecules exist in clusters 
called nucleoids adjacent to the respiratory chain where they are prone to oxidative 
nucleotide base damage from ROS byproduct production. Mutated mtgenomes have the 
ability to expand clonally, eventually causing an energetic defect (Chandra & Singh, 
2011; Schmitt et al., 2012). 
 Energetic defects in both inherited and somatic mutated mtgenomes have been 
implicated in forms of blindness, deafness, movement disorders, dementias, 
cardiomyopathy, myopathy, renal dysfunction and aging (Chan, 2006; Chandra & Singh, 
2011). There is an ever growing list of disease phenotypes being characterized by 
mitochondrial dysfunction with ill-understood patterns of disease initiation and 
progression (Payne et al., 2013). Currently there is no pharmaceutical cure for any 
mitochondria-related diseases (Nunnari & Suomalainen, 2012). With the severity of most 
mitochondrial diseases states, this organelle is an emerging topic of study. 
 Although mitochondria have been studied as a therapeutic target (Wallace et al., 
2011), few studies have assessed the effects of environmental toxicants on mitochondria. 
Environmental toxicants are ubiquitous in our environment with continuous release from 
various sources including industrial and consumer activity (Meyer et al., 2013). Among 
these, environmental estrogens are of particular concern given their prevalence in a wide 
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range of products (i.e., pesticides, plastics, pharmaceuticals and household products) and 
potent estrogenic activity that modulates and/or disrupts a variety of animal systems 
(Hecker & Hollert, 2011; Tyler, Jobling, & Sumpter, 1998). Many studies have 
demonstrated environmental estrogens induce physiological and developmental 
dysfunction on both aquatic and terrestrial species at environmentally relevant 
concentrations.  
 Two of the best exemplified studies are a 7-year whole lake experiment in 
Ontario, Canada and the analyses of English river systems receiving effluent from 
wastewater facilities. In the whole lake exposure Kidd and colleagues demonstrated that 
chronic exposure of 17α-ethynylestradiol (i.e., synthetic estrogen) at environmentally 
relevant concentrations led to the near collapse of the lake fathead minnow (Pimephales 
promelas) population. The decline was linked to both the feminization of males, which 
reduced levels of sperm production, and altered oogenesis in females, which resulted in 
decreased offspring survival (Kidd et al., 2007).  
 Other studies investigating the impacts of estrogenic contaminants on aquatic 
species have observed aneuploid sperm formation (Brown, Schultz, Cloud, & Nagler, 
2008) and reduced embryonic survival following parental exposure in rainbow trout 
(Brown, Schultz, & Nagler, 2007), reduced female reproductive success in zebrafish 
(Coe, Söffker, Filby, Hodgson, & Tyler, 2010) and intersex males (i.e., phenotypic male 
with gonads containing both testicular and ovarian tissue) in roach (Flores & Hill, 2008; 
Tyler & Jobling, 2008). Such effects are not limited to aquatic organisms with similar 
studies conducted in mice and rats having also shown developmental disturbances and 
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reproductive anomalies including: reduced sperm counts in males (Takahashi & Oishi, 
2006), increased oocyte aneuploidy (Susiarjo, Hassold, Freeman, & Hunt, 2007), reduced 
sex accessory organ weights (Takahashi & Oishi, 2006), and disruptions in oogenesis 
(Hunt & Hassold, 2008). Similar to the findings in aquatic vertebrates, many of the 
observed detrimental effects in terrestrial models also occurred with environmentally 
relevant doses. 
 Environmental estrogens, including synthetic estrogens and estrogen mimicking 
compounds, are of particular concern due to their environmental prevalence and potency 
in altering reproductive traits. Contaminants originate from a variety of sources with one 
of the most prominent mechanisms of environmental release occurring through 
wastewater effluent (Desbrow & Routledge, 1998; Hamid & Eskicioglu, 2012; Pollock, 
Dubé, & Schryer, 2010; Ternes et al., 1999). Synthetic estrogens, such as 17α-
ethynylestradiol (EE2), are widely used as pharmaceutical contraceptives for humans and 
animals as well as for hormone replacement therapy for post-menopausal women (Rogan 
& Gladen, 1985).  
 Vertebrate animals, including humans, primarily excrete estrogens through the 
urinary system in a conjugated and biologically inactive form. This conjugated, inactive 
form is highly soluble in water and easily transported in waste water. Despite this, the 
active unconjugated form of estrogen is the dominant form found in the influent and 
effluent of waste water treatment facilities. The process of converting the compounds 
from inactive to active forms after excretion occurs through an enzymatic process with 
bacteria de-conjugating the estrogens and converting them to their biologically active 
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forms. This fluctuation between the inactive and active form of estrogen compounds 
results in inaccurate detection and reduced efficacy of removal processes at waste water 
treatment plants. Although these treatment facilities still reduce the concentrations 
following waste water treatment, environmental estrogenic effects are still observed at 
low doses on a variety of species (Ingerslev, Vaclavik, & Halling-Sørensen, 2003; Kolpin 
et al., 2002; Schultz, Orner, Merdink, & Skillman, 2001).  
 Although there are clear indications that environmental estrogens have direct 
effects on development and reproductive functions, few studies have analyzed the 
potential for these compounds to alter mitochondrial genomic structure despite 
mitochondria having the ability to bind estrogen. Endogenous estrogens bind to estrogen 
receptors (ERs) eliciting complex cellular interactions through membrane, nuclear, and 
mitochondrial signaling pathways (Ropero, Alonso-Magdalena, Ripoll, Fuentes, & Nadal, 
2006). The import of ERs into the mitochondria (mtERs) allows them to modulate 
estrogenic activity within mitochondria, coordinate mitochondria-nuclear regulatory 
cross-talk, and affect overall concentration and distribution of anti-apoptotic proteins 
(Kaipparettu et al., 2013; Spinazzola & Zeviani, 2007). An environmental estrogens 
capacity to bind ERs and elicit estrogenic responses is subject to the chemical structure of 
the foreign estrogen and ER binding affinities within target tissues (Shyu, Cavileer, 
Nagler, & Ytreberg, 2011). 17-α ethynylestradiol (EE2) is a potent estrogenic compound 




 Danio rerio, zebrafish, are a small freshwater tropical fish originating from East 
India. Zebrafish have become a valuable vertebrate model organism used in various areas 
of study; developmental, reproductive, genetic, toxicological, and biomedical (Brown et 
al., 2012; Soares et al., 2009). There are multiple advantages to using zebrafish as a study 
model compared to other common vertebrate models (e.g., mice). Among these, the most 
obvious are that zebrafish are relatively inexpensive to maintain, produce a large number 
of offspring per mating and have a rapid generation/gestation period. Zebrafish embryos 
develop outside of the mother and development processes are fairly visible due to the 
transparency of the egg membrane.  
 In zebrafish, both the nuclear and mitochondrial genomes have been fully 
sequenced (Broughton, Milam, & Roe, 2001). The use of zebrafish in studies 
investigating the mitochondrial genome is particularly useful because of its many 
commonalities to other vertebrates. Zebrafish mtgenome gene order and content are 
identical to the majority of vertebrates, including humans, making them a valuable tool 
for studying mitochondrial disease states (Howe et al., 2013).  
 Lastly, several laboratory strains of zebrafish exist which are useful in 
understanding heterogeneity (Gladyshev, 2013). Of these strains, the three most common 
laboratory strains include AB, Tu, and WIK. Each strain differs in their initial 
development and historic degree of selective breeding. Continued examination of mtDNA 
variation between strains is necessary for future work using zebrafish as a model given 
mtDNA strain variation may have a role in interstrain phenotypic variation. 
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 To date, no studies have assessed the potential for induced heteroplasmy as a 
result of environmental estrogen exposure. Given that environmental estrogens have the 
potential to cause incidental mitochondrial genomic damage following exposure via 
binding to estrogen receptors and translocation into the mitochondrion (Menuet et al., 
2004), we investigated the effects of 17-α ethynylestradiol (EE2) exposure on 
mitochondrial genome stability. The following studies investigated whether 
mitochondrial heteroplasmy can result from non-native estrogen exposure in fish through 
the following aims: (1) preliminary assessment of short-term EE2 exposure on aged 
isogenic male trout mitochondrial DNA, (2) acute EE2 exposure effects on mitochondrial 
DNA during sexual differentiation on full-sib offspring using three strains of zebrafish 
with comparisons to baselines rates from aged strain specific fish and (3) assess the 
effects of chronic EE2 exposure on mitochondrial DNA during full-sib offspring 
development in three strains of zebrafish.  
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Chapter II: Preliminary study on trout 
Introduction 
 Environmental estrogens are a potent class of toxicants found ubiquitously in our 
environment as a result of their wide range use in commercial and industrial products 
including pesticides, plastics, and pharmaceuticals (Fenske, Maack, Schäfers, & Segner, 
2005; Ropero et al., 2006). Environmental estrogens present a significant health concern 
as numerous studies have demonstrated synthetic estrogens modulate and/or disrupt a 
variety of animal systems (Hecker & Hollert, 2011). Such studies demonstrating 
physiological and developmental dysfunction on both aquatic and terrestrial vertebrate 
species within environmentally relevant concentrations include: reduced sperm 
production, altered spermantogenesis, intersex and complete feminization of males, 
altered female oogenesis and induction of aneuploidy in both sexes (Brown et al., 2008; 
Hunt et al., 2003; Kidd et al., 2007; Schultz, Skillman, Nicolas, Cyr, & Nagler, 2003; 
Takahashi & Oishi, 2006; Tyler & Jobling, 2008).  
 While naturally occurring estrogens bind to estrogen receptors (ERs) and elicit a 
complex range of cellular actions through membrane, nuclear, and mitochondrial 
signaling pathways, the capacity of synthetic estrogens to bind to ERs and initiate an 
estrogenic response is subject to the chemical structure of the foreign estrogen and ER 
binding affinities in the target organs (Menuet et al., 2004). The most commonly used 
synthetic estrogen, 17-α ethynylestradiol (EE2), is found in most contraceptive products 
and hormone replacement therapies. EE2 has been demonstrated to be more potent than 
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the endogenous estrogen, estradiol-17 β (E2), in many fish species with a greater 
estimated binding affinity (Shyu et al., 2011). 
 Mitochondria as targets of environmental toxicants is gaining increased 
recognition (Meyer et al., 2013). Assessing the impact of synthetic estrogens on 
mitochondrial integrity is significant given the import of ERs into the mitochondria 
(mtERs) modulates estrogenic activity within the mitochondria and coordinates 
mitochondria-nuclear regulatory cross-talk. The importance of mitochondria cannot be 
understated as they are vital subcellular organelles key to all aspects of development, 
metabolism and growth (Nunnari & Suomalainen, 2012; Youle et al., 2012). They are 
responsible for cellular life-death decisions and also play critical roles in other 
physiological processes (Cheng & Ristow, 2013).  
 One significant factor in mitochondrial function is their genetic material, 
mitochondrial DNA (mtDNA) with all mitochondria having multiple copies of the 
genome within each organelle (Falk et al., 2014). MtDNA can have increased 
susceptibility to environmental genotoxins as a result of their physical location near 
reactive oxygen species (ROS) production sites, reduced protein packing and reduced 
repair capacity. Mutations within the mtDNA are known to cause a wide range of 
physiological disorders including: neurodegenerative disorders, cardiomyopathies, 
metabolic syndromes, cancer, obesity and premature cell senescence (Goldstein, Bhatia, 
& Vento, 2013; Schapira, 2006; Wallace & Chalkia, 2016). Disease phenotype and 
severity is often dependent on the proportion of wild type and mutant mtDNA within an 
individual, or mtDNA heteroplasmy. While many mitochondrial related disease states are 
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strictly hereditarily acquired, to date no studies have assessed the potential for induced 
heteroplasmy as a result of environmental estrogen exposure.  
 The following study is a preliminary investigation assessing the effects of short-
term EE2 exposure on mtDNA stability in sexually mature male isogenic rainbow trout.  
Methods 
 The following was done at the Pacific Northwest National Laboratory in 
accordance to the guidelines established by the Institutional Animal Care and Use 
Committee (IACUC). Male isogenic rainbow trout (O. mykiss) hybrid clones (OSU X 
Swanson) were obtained from Washington State University and reared to 32 months of 
age in circular 1,400-L tanks under pass flow-through freshwater system with in-flow 
rates between 15-20L/min (Young & Wheeler, 1992). Water was sourced from Battelle 
Marine Science Laboratory’s artesian well (depth = 134m) in Sequim Washington and 
aerated before transfer to holding tanks. Tank quality parameters were routinely measured 
in all tanks and include: temperature (mean: 11.2 oC; range: 10.9 – 11.4 oC), dissolved 
oxygen (>9 mg/L) and pH (mean 7.9; range: pH 7.8 – 8.1). Trout were fed a moist 2-
6mm pellet feed from Vitalis Bio-Oregon Inc. (Longview, WA USA) at a ration level of 
approximately 0.75% body mass to encourage growth. Trout were maintained under 
lighting that simulated a natural photoperiod that included a 12-minute graded sunrise 
and sunset period. 
 The 17 α-ethynylestradiol was purchased from Sigma-Aldrich. All other 
chemicals were reagent grade. At 32 months of age, trout were exposed to 17α-
ethynylestradiol using a continuous flow protocol for fifty (50) days. Exposure solutions 
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were prepared and added slowly using a peristaltic pump. Exposure tanks were 
equilibrated for three days prior to fish exposure. Trout were exposed to a nominal EE2 
exposure level of 10ng/L. Control trout were unexposed to EE2 but handled and 
maintained as those under treated fish conditions. 
 After fifty days exposure, trout were euthanized using MS-222 by anesthetic 
overdose. Livers were excised immediately following death and rinsed with cold buffer 
solution described by Frezza (Frezza, Cipolat, & Scorrano, 2007). 
 Liver tissue was homogenized using glass Teflon homogenizers performed at 4°C 
to minimize damage caused by phospholipases and proteases. A two-phase sucrose 
gradient differential centrifugation to enrich for functional mitochondria was performed. 
The first phase isolated cellular debris through low speed centrifugation while the second 
isolated mitochondria through high speed centrifugation (Frezza et al., 2007). 
Mitochondrial DNA was extracted from the pellet using DNeasy Blood & Tissue Kit 
(QIAGEN) following standard tissue protocols.  
 Nucleic acid quantification was performed using NanoDrop 2000 UV-Vis 
Spectrophotometer. Using two mitochondrial specific primers and one nuclear specific 
primer, we assessed the proportion of mtDNA to nuclear DNA. Genes were amplified in 
10µL reaction mixtures (Taq DNA polymerase, forward and reserve primers and BSA) 
containing: 1µL DNA template, concentration range 55-90ng/µL). 
 Extracted DNA was sent to Oregon Health and Science University’s Massively 
Parallel Sequencing Shared Resource (MPSSR) for library preparation, barcoding, and 
sequencing. Sequencing was performed using the Illumina HiSeq 2000 Sequencer.  
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 Using Bowtie 2 v2.1.0, we mapped sequence reads against trout mitochondria 
reference genome (accession L29771) using default indexing parameters. Raw paired-end 
sequence data were mapped to each index using default alignment parameters in Bowtie 
2 v2.1.0. Using Bowtie2 SAMtools we generated a binary BAM format, sorted the BAM 
file and ran mpileup to produce a format of each line representing a genomic position. A 
Python script was used to convert to data files which were accessible for further analysis 
of frequency of nucleotides diversity per site. 
Results and Conclusions 
 We used PCR amplification to assess for genomic DNA contamination and verify 
enrichment of mtDNA content post organelle isolation on one EE2 treated sample, 107 
and one control sample, 105.1 (Figure 3) against a test sample of total Swanson Clone 
DNA. Mitochondrial enrichment proved highly successful with little to no detectable 
nuclear DNA present in amplification. 
 Three fish treated at 10ng EE2/L and three untreated controls were used for 
comparison. We achieved an overall coverage of 8000x across all samples sequenced. We 
defined heteroplasmy as the second most common base variant per site across the 
mitochondrial genome. A sequencing error rate of 0.0004 or 0.04% was determined by 
comparing sequencing replicates of one control sample through the difference between 
the absolute value of heteroplasmic frequency between each site and determining the 
average across the genome. A linear regression comparing heteroplasmy between 
sequencing replicates demonstrated high consistency in same lane sequencing as seen 
with a R2 of 0.9939 (Figure 4). 
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 We established a conservative threshold of heteroplasmic calls to be ≥0.25% or 5x 
our sequencing error rate. Heteroplasmic calls were not found to be statistically 
significant between treated and control fish (Figure 5) although there was an increase in 
the number of heteroplasmic sites in almost all EE2 treated fish compared to the control 
(Table 1). Out of all EE2 treated fish, the lowest number of sites considered 
heteroplasmic is slightly greater than the highest number of sites in the control fish. 
Using UCSC Genome Browser to map heterplasmic sites to the mitochondrial genome, 
and observed site specific mutations in EE2 treated fish compared to the control (Figure 
6). 
 We found consistency between sequencing replicates demonstrating low 
sequencing error rate when using Illumina Next-Generation Sequencing technology. 
Although we achieved high depth of coverage, 8000x in our approach for mtDNA 
enrichment, we desired greater coverage for our subsequent experimental treatments to 
ensure greater confidence in determining heteroplasmic calls. Even with our low sample 
size, n=3 per group, we see site specific mutations and an overall increase in 
heteroplasmy between treated and untreated fish. This preliminary study provided a base 
for improving technique and supports continued investigation of assessing whether 







Figures and tables 
 
Figure 3: PCR amplification assessing genomic DNA contamination 
after mitochondrial organelle isolation in EE2 treated trout sample, 
107 and control sample, 105.1 against test sample SW containing total 
DNA. 
 
Figure 4: Linear regression of heteroplasmy between sequencing replicates in trout 





Figure 5: Average number of heteroplasmic sites ≥0.25% between EE2 treated (red) and 
control (green) trout (p>0.05). 
 
 
Table 1: Heteroplasmic sites ≥0.25% in 
EE2 treated vs control trout samples 
Sample ID 
Heteroplasmic 





EE2 107 710 
EE2 104-1 1015 





Figure 6: Mutational frequencies ≥0.25% viewed in UCSC genome browser in control (green) and EE2 




Chapter III: Acute treatment study and baseline comparisons 
Introduction 
 Environmental estrogens are a potent class of toxicants found ubiquitously in our 
environment as a result of their wide range of uses in commercial and industrial products 
including pesticides, plastics, and pharmaceuticals (Fenske et al., 2005; Ropero et al., 
2006). Environmental estrogens present a significant health concern as numerous studies 
have demonstrated synthetic estrogens modulate and/or disrupt a variety of animal 
systems (Hecker & Hollert, 2011). Such studies demonstrating physiological and 
developmental dysfunction on both aquatic and terrestrial vertebrate species within 
environmentally relevant concentrations include: reduced sperm production, altered 
spermantogenesis, intersex, complete feminization of males, altered female oogenesis and 
induction of aneuploidy in both sexes (Brown et al., 2008; Hunt et al., 2003; Kidd et al., 
2007; Schultz et al., 2003; Takahashi & Oishi, 2006; Tyler & Jobling, 2008).  
 While naturally occurring estrogens bind to estrogen receptors (ERs) and elicit a 
complex range of cellular actions through membrane, nuclear, and mitochondrial 
signaling pathways, the capacity of synthetic estrogens to bind with ERs and initiate an 
estrogenic response is subject to the chemical structure of the foreign estrogen and the ER 
binding affinities in the target organs (Menuet et al., 2004). The most commonly used 
synthetic estrogen, 17α-ethynylestradiol (EE2), is found in the majority of contraceptive 
products and hormone replacement therapies. EE2 has been demonstrated to be more 
potent than endogenous estrogen, estradiol-17 β (E2), in many fish species with a greater 
estimated binding affinity (Shyu et al., 2011). 
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 Mitochondria as targets of environmental toxicants is gaining increased 
recognition (Meyer et al., 2013). Assessing the impact of synthetic estrogens on 
mitochondrial integrity is significant given the import of ERs into the mitochondria 
(mtERs) modulates estrogenic activity within the mitochondria and coordinates 
mitochondria-nuclear regulatory cross-talk. The importance of mitochondria cannot be 
understated as they are vital subcellular organelles key to all aspects of development, 
metabolism and growth (Nunnari & Suomalainen, 2012; Youle et al., 2012). They are 
responsible for cellular life-death decisions and also play critical roles in other 
physiological processes (Cheng & Ristow, 2013).  
 One significant factor in mitochondrial function is their genetic material, 
mitochondrial DNA (mtDNA) with all mitochondria having multiple copies the genome 
(Falk et al., 2014). MtDNA can have increased susceptibility to environmental genotoxins 
as a result of their physical location near reactive oxygen species (ROS) production sites, 
reduced protein packing and reduced repair capacity. Mutations within the mtDNA are 
known to cause a wide range of physiological disorders including: neurodegenerative 
disorders, cardiomyopathies, metabolic syndromes, cancer, obesity and premature cell 
senescence (Goldstein et al., 2013; Schapira, 2006; Wallace & Chalkia, 2016). Disease 
phenotype and severity is often dependent on the proportion of wild type and mutant 
mtDNA within an individual, or mtDNA heteroplasmy. While many mitochondrial 
related disease states are hereditarily induced, to date no studies have assessed the 
potential for induced heteroplasmy as a result of environmental estrogen exposure.  
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 The goal of this study was to examine the effects of EE2 on mitochondrial 
genome stability after acute exposure to zebrafish during the bio-energetically demanding 
period of sexual differentiation. In addition, we assessed the effects of EE2 on the 
proportion of females between untreated fish and treatment groups, tracking survivorship 
between environmentally relevant treatment concentrations. Lastly, because mitochondria 
is maternally inherited, we used the maternal lines for comparison of full-sib treatment 
groups as well as fish for baseline comparison from each strain to assess standing rates of 
heteroplasmy. 
Methods 
 All fish were maintained in accordance to guidelines established by the 
Institutional Animal Care and Use Committee (IACUC) of Portland State University. 
Adult male and female zebrafish, of the three common laboratory strains AB, Tu, and 
WIK, less than one year of age were obtained from the Zebrafish International Resource 
Center (ZIRC) for use as either baseline analysis fish, maternal lines or for the generation 
of full-sib treatment groups. Fish were housed in 2.8-liter baffled flow-through tanks at a 
ratio of 1 male: 1 female with a stocking density of 10 or less fish per 2.8L tank in the 
Brown Zebrafish Aquatics Facility at Portland State University. Fish were maintained on 
the Aquaneering Modular System with 4-stage central filtration providing continuous 
flow-through of recirculating water with a twice daily automated 10% water change. This 
system monitors and maintains parameters within a narrow range to ensure 
environmental effects are negligible. The aquatic facility utilizes a photo period of 15h 
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light: 9 hr dark. Adult fish were fed two times a day ad libitum with larvae power and live 
Artemia salina (brine shrimp). 
 Sexually mature zebrafish used for generation of treatment fish were set up as 
breeding pairs (1 male:1 female) in Aquaneering Crossing Tanks with dividers to separate 
each pair. The following morning, dividers were removed and zebrafish were allowed to 
spawn for up to 6 hours. Spawning occurred within the aquatic facility under standard 
room and system parameters. 
 Embryos were collected, rinsed with embryo media (Cold Harbor Springs 60x 
recipe), and kept at a stocking density of ≤50 embryos per petri dish in media at 28°C for 
5 days. At 5 days post fertilization (dpf) hatched larvae were transferred to static tanks 
containing ~250mL media with water changes performed daily. Larvae were fed 
concentrated rotifers twice daily ad libitum. At 9dpf larvae began transition to live brine 
shrimp in addition to rotifers. At 11dpf larvae were transferred to the main system and 
placed under a slow drip of ~1 drop/second. Larval powder was introduced at 14 days 
and fish were transitioned to an adult feeding schedule at 3 weeks of ago. Juveniles were 
raised under these conditions until 6 weeks of age for exposure initiation.  
 The exposure system (Figure 7) was designed and built in house. 20-gallon fish 
tanks were used as common mixing tanks (x4 treatment groups) and 1 gallon fish bowls 
were used as treatments tanks to house respective pair/strain/treatment type (2 pairs per 
strain, 3 strains). Using PVC piping and a centrifugal pump, pre-mixed exposure water 
was routed circularly with an inflow ball valve into 1 gallon fish bowls. Each exposure 
tank had an outflow valve routed into a common waste basin which was pumped through 
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a triple filtration system before flowing into the common building drainage and city 
wastewater system. Common mixing tanks were spiked with EE2 or methanol (for 
control) and allowed to equilibrate for 24 hours prior to transfer of juvenile fish. 
 The test compound 17α-ethynylestradiol (EE2) was obtained from Sigma-Aldrich 
( ≥ 98% purity grade). EE2 was solubilized in 100% methanol at a ratio of 1mg/1mL. A 
final working concentration of 10ng EE2/µL in 10% methanol was prepared as the final 
exposure working stock for spiking treatment water. Control fish were exposed to 
methanol at the highest EE2 treatment concentration, 9.5µL methanol/gallon tank water 
or ≤0.00025%.  
 At 6-weeks of age, following sexual differentiation, juvenile zebrafish (Danio 
rerio) from strains AB, Tu, and WIK were exposed for 6 weeks to nominal values of 10ng 
EE2/L, 100ng EE2/L, and 250ng EE2/L (Figure 8). Control fish were exposed to 
≤0.00025% methanol, equivalent to the greatest amount of methanol used on the 250ng 
EE2/L treated fish. Two sets of full-sib juveniles were used for each strain totaling six 
families per treatment type. 
 Two acute treatment series were performed (acute exposure (1) and acute 
exposure (2)). During the initial trial, an immediate die-off of juvenile fish was observed 
and discovered to be a result of low water conductivity, 0.02ppt. Initial common mixing 
tank water was sourced from the main system’s fresh water sump after dechlorination 
which reduced ions levels below acceptable levels. Hours into the initial exposure, 2ml 
NaCl/gallon was added to common mixing tanks. Thereafter, each common mixing tank 
fill included 2ml NaCl per gallon of water. We had a target of 20 individuals per pair and 
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treatment. For the duration of the treatment, exposure water was semi-static with daily 
30-second flushes per bowl. 
 Baseline fish were also tested to establish nominal background rates of 
heteroplasmy between strains. Ten adult zebrafish (5 females and 5 males) from each of 
the three strains were raised under standard rearing conditions to 2 years of age, as 
described above. Assessment of these fish will ensure that baseline heteroplasmic 
frequencies are similar between untreated and methanol only treated individuals as well 
as for comparison of between strain variations. 
 Fish were euthanized using MS-222 (Sigma-Aldrich) at a concentration of 
300mg/L water at pH 8 for ≥15 minutes. Weight and sex was recorded prior to liver 
extraction. Liver tissue was collected from zebrafish by surgical manipulation under a 
stereoscopic microscope (Leica Microsystems) and stored at -20°C until further use. 
 Total DNA was isolated from liver tissue using QIAGEN DNeasy Blood & Tissue 
Kit. Nucleic acid quantification was performed using NanoDrop 2000 UV-Vis 
Spectrophotometer. To assess for mtDNA in total DNA, two primer pairs of 
mitochondrial encoded protein subunits for cytochrome b and one primer pair of nuclear 
encoded protein subunit for rhodopsin were used. Genes were amplified in 10µL reaction 
mixtures (Taq DNA polymerase, forward and reserve primers and BSA) containing: 1µL 
DNA template, concentration range 55-90ng/µL. 
 We used custom designed Agilent SureSelectXT Target Enrichment Kit for 
Illumina Multiplex Sequencing to capture the following 5 genomic regions of interest: 
mitochondrial genome (1-16596bp), chromosome 19 (9838621-9841031bp), 
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chromosome 22 (17417393-17419398bp), chromosome 22 (17422326-17422970bp) and 
chromosome 7 (31329397-31333402bp). Four probes were designed for regions of the 
nuclear genome, three for mitochondrial encoding nuclear genes (ndufv1 - NADH 
dehydrogenase of complex I, and two regions ATPAF1 - assembly factor of ATP 
synthase) and one for a non-mitochondrial related nuclear encoded gene (isl2b - insulin 
gene enhancer protein). 
 Paired-end Illumina libraries were captured in accordance to the SureSelect 
protocol with the following modifications. Input DNA and buffer for fragmentation was 
doubled to 6µg DNA into 260µL total volume 1x TE buffer. Sonication was performed 
for a median fragment target size of 150-200bp on Cole-Parmer Ultrasonic Processor at 
60% amplitude, for a total of 4.5 minutes sonication time with on-off intervals of 9-30 
seconds on and 8-30 seconds off. For the first sample purification step using Agencourt 
AMPure XP beads, input bead volume and concentration of sheared DNA library was 
doubled. The products were end-repaired, 3’non-template A’s were added, and pair-end 
adapters were ligated. Ligated libraries were PCR amplified for 6 cycles.  
 DNA libraries were hybridized to custom biotinylated probes with subsequent 
immobilization on magnetic beads. After elution of the captured target regions, libraries 
were amplified with 1 of 16 unique index primer tags for each sample in accordance to 
intra or inter lane sequencing design.  
 Quantification and quality assessment of indexed-captured libraries was done 
using Agilent 2100 Bioanalyzer and qPRC at Oregon Health and Science University’s 
Massively Parallel Sequencing Shared Resource (MPSSR). Index-tagged libraries were 
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pooled for multiplexed sequencing. Using the Illumina HiSeq 2000 Sequencer, 100-bp 
paired-end reads were generated for each sample. 
 Using Bowtie 2 v2.1.0, we prepared three indexes for reference using default 
indexing parameters. For the zebrafish mtDNA reference, GRCz10 (GB 
GCA_000002035.3) was used to prepare the first index (mtDNAindex). Because the 
mtgenome is a circular molecule, we prepared a 936bp long concatenated index 
(concatenated_mtDNA_index) by manually clipping the first 456 bp and last 480 bp 
locations and wrapping them to close the genome. A third index was created using the 
zebrafish reference Zv9 (GCA_000002035.2) by selecting out the nuclear target regions 
per probe design. The GRCz10 reference release is an improved assembly of Zv9 which 
was a preliminary assembly; however MT assemblies are identical within the two 
versions. The Zv9 assembly was used as an index to our nuclear probes based on the 
design date of our probes being prior to the release of the revised assembly. 
 Raw paired-end sequence data were mapped to each index using default 
alignment parameters in Bowtie 2 v2.1.0. Using Bowtie2 SAMtools we generated a 
binary BAM format, sorted the BAM file and ran mpileup to produce a format of each 
line representing a genomic position. A Python script was used to convert to data files 
which were accessible for further analysis of frequency of nucleotides per site. 
 Exposure water samples (400mL) were collected weekly throughout the duration 
of the exposure. Control water samples (400mL) were collected at the half-way and final 
week time points of the exposure duration. Both exposure water and control samples 
were immediately spiked with internal standard (50ng IS/L). Samples were stored at -
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20°C until further analysis. Samples were thawed to room temperature 24 hours prior to 
sample preparation for quantification. 
 Compounds used for LC-MS analysis include the following: triethylamine (TEA) 
and 17α-ethynylestradiol (EE2) were obtained from Sigma-Aldrich. Acetonitrile (ACN) 
and water (LC–MS grade) were from Burdick and Jackson (Muskegon, MI). 17β-
Estradiol-16, 16, 17-d3 (E2D3) was from Toronto Research Chemicals Inc. 
 Quality control samples were generated at concentrations of 10, 100, and 250ng 
EE2/L using dilutions of authentic standard in methanol as in those used to spike 
common mixing tanks. Calibrators were generated to cover the concentration range of 
EE2 in mixing tank water from 1ng-250ng EE2/L using dilutions of authentic standard 
dried and reconstituted in mobile phase. 
 D3 tagged estradiol (E2D3) was used as an internal standard (20μL at 1ng/µL) in 
100% methanol added to QC samples, samples and calibrants. 400mL samples or QC 
samples were passed through a 3mL Oasis HLB SPE cartridge (Waters) conditioned with 
3mL of methanol using a vacuum manifold.  Analytes were eluted using 2mL methanol, 
dried under a vacuum, and reconstituted in 100µL starting mobile phase.  
 LC–ESI-MS analyses were performed using a high-resolution (30,000) Thermo 
LTQ-Orbitrap Discovery hybrid mass spectrometry instrument (San Jose, CA) equipped 
with an electrospray ionization source operating in the negative mode. The ESI interface 
using the following settings: sheath gas flow rate 40 (arbitrary units), aux gas flow rate 15 
(arbitrary units), spray voltage 2kV, capillary temperature 250C, capillary voltage -17 V, 
and tube lens voltage -85 V. The Orbitrap was externally calibrated prior to data 
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acquisition allowing accurate mass measurements for [M+H]+ or [M-H]- ions to be 
obtained to within 4ppm. 
 The Orbitrap was coupled to a Thermo Accela HPLC system. EE2 was resolved 
using a Kinetex C18 (4.6x50mm, 2.1 mm i.d., 2.5uL particle size) HPLC column with 
guard cartridge (Phenomenex; Torrance, CA). Mobile phases consisted of 0.025% TEA in 
HPLC grade water (A), 0.025% TEA in 95:5 methanol:water (B). The gradient mobile 
phase was delivered at a flow rate of 0.3 mL/min and the TEA:water mobile phase.  
 Start conditions were 5% B, increased to 40% B over 2 minutes, increased to 45% 
B over the next 5 minutes, 100% B over the next three minutes. Column was washed at 
100% B for 1 minute and back to 5% B for 5 minutes. The column temperature was kept 
at 25°C using a thermostatic column oven. The sample injection volume was 50 μL. 
Results and Conclusions 
 We exposed 6 groups of full-sib offspring from 3 strains of zebrafish: AB, Tu, and 
WIK, across 4 treatment categories: 10ng, 100ng, 250ng EE2/L and control (methanol 
≤0.00025%) to assess the effects of EE2 on mitochondrial genome stability during sexual 
differentiation, 6 weeks of age. We observed lethality among 100ng and 250ng EE2/L 
treatment groups limiting our sequencing comparisons to the control and 10ng EE2/L 
treatment group. We used Illumina next generation sequencing technology for sequencing 
ultra-pure mtDNA after target enrichment from liver tissue of acute exposure (2) study 
groups (Table 2): (a) 10ng EE2/L and control (at ≤0.00025% methanol) for 6 weeks, from 
three strains of zebrafish AB, Tu, and WIK, using two separate maternal/paternal (1-1ab, 
8-3ab, 2-1tu, 7-3tu, 1-1wik, 1-2wik) lines per strain; (b) the maternal line, as above, from 
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each pair used to generate full-sib offspring for treatments; (c) 10 baseline fish (5 males 
and 5 females) over 2 years of age from each strain; and lastly, (d) five replicate samples 
(not in table) from each representative group to correct for sequencing error.  
 Actual start counts consisted of 13-23 acute exposure (1) and 18-21 acute 
exposure (2) due to natural die off during the first 6 weeks of rearing in untreated system. 
We were interested in comparing the survivorship of each treatment type (10ng, 100ng, 
and 250ng EE2/L) to control (≤0.00025% methanol) using three zebrafish strains (AB, 
Tu, and WIK) (Figure 9-12, top from acute exposure (1) and bottom from acute exposure 
(2)). During the initial acute exposure (1), we had 2 issues: (a) initial counts were lost 
because of recording errors, (b) rapid initial die-off within all treatment and control 
groups predominantly in strain Tu. Survival curves from acute exposures (1) which begin 
past day 0 show the first day of accurate counts for the associated strain and treatment 
type recorded (e.g. acute exposure (1) 250ng EE2/L, TU-1 begins at 76% on day 14, 
meaning between day 0-14 seven individuals were lost without record of individuals lost 
per day). The rapid die-off was quickly discovered to be the result of low conductivity in 
sourced water as described in the methods. The general trend seen from the acute 
exposure (1) after initial die-off and start of survival counts was found to be 95% or 
greater survival in the control and 10ng EE2/L groups across all three zebrafish strains 
and 50% survival or less across all three strains of 100 and 250ng EE2/L treatment 
groups. 
 Survivorship for acute exposure (2) series had similar patterns to exposure (1). 
Greater than 95% survival was seen in all pairs and strains in the control group of acute 
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exposure (2) with the exception of Tu pair 2.1; however, 30% loss in this pair/strain 
occurred within the first 2 days of the exposure start date and remaining die-off, 5% 
occurred within the first 4 days of exposure start which was likely associated with 
acclimation sensitivity following tank transfer. Post-day 4, Tu 2.1 had 100% survival. All 
pair and strains within 10ng EE2/L treatment had greater than 90% survival lacking any 
indication of lethality at this concentration. As seen in acute exposure (1), both 100ng and 
250ng EE2/L were found to be lethal in all 6 pairs used with the exception of WIK 1.1 at 
100ng EE2/L which concluded the treatment at 55% survival. Phenotypically, surviving 
individuals in 100ng and 250ng EE2/L treatment groups were greatly reduced in size and 
weight, had a great degree of ascites, raised scales, and in some cases bulging eyes, and 
enlarged hearts suggesting severe impairment of growth and developmental pathways and 
inhibition of normal organ function. 
 Until 2013, sexual determination and differentiation pathways in zebrafish were 
considered mostly unknown. Liew and Orban (2013) did an overview of zebrafish sex in 
two strains of zebrafish (AB and Singapore based wildtype) where they identified three 
major developmental pathways associated with gonad differentiation but concluded 
further analysis is necessary to elucidate this process. With sexual differentiation 
occurring 21-30 dpf (Liew, Bartfai, Lim, Sreenivasan, & Siegfried, 2012), and our 
exposures beginning following sexual differentiation, 42 days of age, we were interested 




 The proportion of females post-42 day acute exposure (2) between control and 
treatment (Figure 13) was not statistically significant; however, an increase was observed 
in the proportion of females in 10ng EE2/L compared to controls. In the 100ng and 250ng 
EE2/L treatment groups of each strain and pair, either 0% survival occurred or among the 
few surviving individuals (≤55%), gonad type could not be determined from gross 
dissection. This appeared to be due to stunted growth and severe fluid within the body 
cavity.  
 Calibration curves were generated by performing a least-square linear regression 
for peak area ratios (EE2 analyte/E2D3 internal standard) plotted against specified 
calibrant concentration in water (ng/L). The lower limit of quantification (LLOQ) was 
determined as the lowest concentration for which the signal-to-noise (S/N) ratio was ≥5 
and the within- and between-day reproducibility of the peak area was ≤20% relative 
standard deviation (RSD). For all other calibrators the between and within-run precision 
(RSD) for calculated concentration across the range 1-250ng/L was ≤15% and accuracy 
was within ±15% (detailed precision and accuracy information for calibrators and low 
and high QCs provided in Table 3). 
 The goal of these experiments was to validate that the measured concentration of 
common tank exposure water to treatment groups was within +/- 25ng EE2/L of spiked 
concentration. The data we generated supported this (Table 4), calculated mean 
concentrations of EE2 in mixing tank samples. In addition, EE2 was not detected in the 
control samples taken from the half-way and end-of-exposure time points of acute 
exposure (2) showing control fish were not exposed to EE2. 
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 Total DNA was isolated from liver tissue and quantified as described in the 
methods with the following two exceptions: (a) the maternal fish from 2-1tu (pair 2-1, 
strain Tu) died of natural causes while on the main aquatic system and upon retrieval, 
adequate DNA for sequencing preparation was not successfully extracted from either 
liver tissue or through fin clip attempts, (b) maternal fish from 8-3ab (pair 8-3, strain ab) 
died of natural causes on the main aquatic system; however, adequate DNA was extracted 
through superior anal fin clip opposed to liver extraction. Because mitochondria are 
maternally inherited the loss of 2-1tu maternal DNA resulted in the exclusion of 2-1tu 
control (M1-M6) and treated fish (10.1-10.6) from the analysis of sequence data. 
 All samples were assessed through gel electrophoresis post-sonication to ensure 
target fragment size of 150-200bp or larger was achieved (Figure 14). During the initial 
stages of working through the protocol, select samples were assessed for quality control 
post-sonication and post-AMPure bead clean-up 1 but prior to library preparation using 
Agilent 2100 BioAnalyzer (Figure 15). Samples were quantified using 1µl DNA at each 
step of the library preparation protocol to ensure adequate DNA content was being 
carried through the procedure.  
 Using target enrichment we achieved an average sequence coverage of >88,900x 
across our entire sequencing project (Tables 5-9). Over 70% of samples sequenced with 
an average coverage >90,000x. The lowest coverage within samples was >1000x at sites 
profiled within the D-loop (between 1-950bp). Overlaid sequence coverage of replicate 
samples demonstrates coverage across the mitochondrial genome and specific regions of 
high vs low coverage. These replicates demonstrate that seen across all sequenced 
36 
 
samples. Overall read counts and alignment to the mitochondrial references genome 
ranged from 6-75million reads and 70.17-98.85% (table 10-14). Of these, 92% of 
sample’s reads mapped at ≥90% and 81% of sample’s reads mapped ≥95% to the 
reference mtgenome.  
 We achieved ultra-high coverage by using target enrichment to select for pure 
mtDNA; however, sequencing error still presents as a challenge of modern sequencing 
technologies. To establish a robust sequencing error rate we used a conservative strategy 
of 5 replicate sample comparison, two within the same lane and three between lanes. To 
ensure we accurately captured an error rate representative of all sample types, we 
sequenced replicates from each group within our study: 1-methanol control, 2-10ng 
EE2/L treated fish, 2-baseline fish and of these, at least one from each strain was used as 
a replicate as demonstrated in overlaid sequence coverage (Figure 16). In addition, we 
sequenced replicates of full sibs from control and treated fish as well. A linear regression 
performed on one of each sample and comparability of between and same lane 
sequencing shows consistency between samples (Figure 17). 
 We defined a heteroplasmic site as the number of calls for the second most 
common allelic variant out of all calls for that site. Our standard for determining error in 
each replicate sample was set by finding the heteroplasmic frequency of each site in both 
replicates, subtracting the absolute value of heteroplasmy at each site and finding the 
average across the entire mtgenome of the replicate differences (Table 15). The difference 
between the highest and lowest error rate found was 0.000078 or 0.0078%. As there was 
little variability between replicates, we established our sequencing error rate to be 
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0.000147 or .0.015%, the highest error rate found out of all our replicate samples. We 
observed a much lower error rate compared to our preliminary investigation by using 
improved techniques and increase sample size. 
 Additionally, we profiled the top ten sites with the greatest heteroplasmic variance 
between replicates (Table 16). Three out of five of our replicate samples top sites of 
variance were entirely within non-coding D-loop of the mtgenome, the most polymorphic 
region of the genome. Of the two other replicates investigated with highly variable sites 
in encoding regions, the WIK replicate had the highest frequency at 7.6% at the top site; 
however, this location, 10535, was found to be strain specific and the top heteroplasmic 
site across all WIK samples sequenced along with the other highly variable sites listed 
within this strain. 
 Through target enrich we were able to obtain highly pure mtDNA for sequencing. 
Sequencing artifacts (eg, adaptor dimers) that could typically compromise actual 
heteroplasmic calls were filtered out through selection with AMPure bead clean-up. The 
addition of paired-end molecular barcodes to adaptor sequences along with at or above 
target fragment length increased our confidence in read quality and alignment strength of 
our 100bp length reads. To ensure our identification of heteroplasmic sites was the result 
of actual allelic variants and not an artifact, we established our heteroplasmic threshold as 
5x our established error rate (0.0015%) at 0.075%. All considered along with our depth of 
coverage, we still set a conservative threshold for resolving actual structural variants, 
allowing for confidence in heteroplasmic calls. Our threshold was applied to all samples 
and any sites with allele frequencies above were considered heteroplasmic sites 
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 Ameur et al. (2011) estimated point mutation frequency by looking at mutations 
per nucleotide and finding the median, reporting a standing frequency of 0.00013-
0.00018 in wild-type mice and 0.0012 in mutator mice expressing a proof-reading-
deficient mtDNA polymerase (Ameur et al., 2011). Additionally, He et al. (2010) 
established heteroplasmic variants 2x their established error rate when comparing tumor 
to normal cells in humans (He et al., 2010).  
 We sequenced mtgenomes from 5 females and 5 males from three strains of 
zebrafish. Using a heteroplasmic threshold of 0.075% (Figure 18), we saw no differences 
between standing rates of heteroplasmy between males and females within the same 
strain or between strains (Figure 19; left side). Additionally, we saw no differences 
between standing rates of heteroplasmy over 0.075% when males and females were 
pooled and strains were compared, AB-2077, Tu-1536, WIK-2289 sites (Figure 19; right 
side).  
 Within strain and pair comparisons of heteroplasmic sites at >0.075% showed the 
standing heteroplasmic frequency of the maternal lines relative to control and treated full-
sibs of that line (Figures 20-22). In each strain we see the frequency of heteroplasmy 
between control groups reflective of standing maternal heteroplasmy and a general 
increase in the 10ng EE2/L treated fish. Heteroplasmy in maternal lines (Figure 23) is 
consistent across strains, similar to what was seen in baseline fish comparisons.  
 When we compare treatment vs control of each pair/strain (Figure 24), a 
statistically significant difference between control and treated is seen within one 
pair/strain combo, 8-3ab; however although it is not statistically significant, there is a 
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consistent trend across all strains and pairs demonstrating an increase in heteroplasmy 
between treatment and control. 
 Comparing pooled control fish to pooled 10ng EE2/L treated fish (Figure 25), we 
see a statistically significant difference between heteroplasmic variants at our determined 
threshold (p<0.05), 2442±439 vs 4462±918. In our final comparison of heteroplasmy 
between all groups: control, 10ng EE2/L treated, baseline and maternal (Figure 26), as 
before we see statistically significant differences between control vs treated but also 
between 10ng EE2/L treated vs baseline groups. This is not seen between baseline and 
control or maternal and control. There was also no difference between maternal and any 
other group however a sample size of only 5 fish appears to limit this comparison to the 
maternal group while each other had a sample size of 30.  
 Within the vertebrate mtgenome, hypervariable sites exist predominantly within 
non-coding regions (i.e., the d-loop). Ameur et al. defined sites with single nucleotide 
variant frequencies (SNV) >0.5% as mutational hotspots, a value also used in both mouse 
and human heteroplasmic studies. We found 1-30% of our heteroplasmic sites to fall in 
this category. By this definition, we saw no clear differences between mutational hotspots 
in treated vs untreated fish within the acute exposure sequencing group. 
 The goal of this study was to examine the effects of environmentally relevant 
concentrations of EE2 on three common strains of zebrafish at the life cycle stage of 
sexual differentiation. Our results show two out of three concentrations of EE2 (100ng 
and 250ng EE2/L) were lethal to all three strains of zebrafish during this stage of 
development. Consistent with other studies, we found exposure to EE2 during sexual 
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differentiation increased the proportion of females relative to control groups; however 
this was not statistically significant. Given that we could only compare the lowest 
concentration of EE2 (at 10ng EE2/L) to the control to assess female proportion, we were 
limited in our comparison across multiple treatment groups. 
 Our sequencing results using SureSelect Target Enrichment for mtDNA selection 
shows ultra-high sequencing coverage with an average of 90,000x across our sequenced 
samples giving us confidence in our heteroplasmic calls. Our use of sequencing five 
replicate samples and unique lane design allowed us to establish an error rate of 0.015% 
and determine a conservative heteroplasmic threshold of 0.075%. Using this threshold, 
we compared heteroplasmic calls within and between strains. Our results show an 
increase in heteroplasmic sites both within and between strains in 10ng EE2/L treated fish 
compared to control; however, the level was not statistically significant. Comparison of 
all treated to untreated fish shows a statistically significant difference between the groups. 
 The loss of two out of three of our treatment groups during exposure greatly 
limited our comparisons of heteroplasmy between treated and untreated fish. With our 
current results indicating an overall increase in heteroplasmy between 10ng EE2/L treated 
fish compared to control fish, continued assessment of these effects are necessary. The 
above assessment is important for understanding the vulnerability of the mitochondrial 
genome to toxicant exposure. Are higher concentrations at different life stages susceptible 
to similar effects? Although the exact mechanisms by which this occurs is still unknown, 
determining the extent of genomic changes to the mitochondrial genome after EE2 
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exposure is the first step in determining whether mtDNA can be a target of 
xenoestrogens. If so, to what extent can these changes alter mitochondrial function? 






Figure 8: Acute exposure design. Three EE2 treatment groups (10, 100, 250ng EE2/L) and one 
methanol control group, three zebrafish strains (AB, Tu, WIK), two breeding pairs per strain to create 
full-sib starts. Six week exposure duration starting at 6 weeks of age. 
Figure 7: Diagram of exposure system used to treat zebrafish to 17-α ethynylestradiol (black arrows 
represent circular flow of exposure water, red arrows represent outflow of waste water, colored fish 
bowls represent three strain designations.) 
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Table 2: Acute exposure (2) sequencing sample key 
Maternal Treated Baseline 
ID Full-sib ID 
MeOH 
cntrl 

































Acute treatment (2) sequencing sample key breakdown. Maternal line: pair ID, strain, f (female). 
Treated fish: pair ID, strain, [either] M (methanol control) or 10- (10ng EE2/L tx), 1-6 (individual ID). 








Figure 9: Percent survival against 42 day treatment duration. Two acute exposure series were 
performed (1) and (2) of control (a) group (with ≤0.00025% methanol, representing the greatest 
amount of methanol used as an EE2 solvent in highest treatment) of three zebrafish strains: AB 
(green), Tu (blue), and WIK (orange). Two maternal/paternal pairs were used per strain to generate 
full-sib offspring represented by two shades of associated color (ie dark blue for pair one and light 
blue for pair two of Tu). Maternal/paternal (m/p) lines used in acute exposure (1) were different than 





Figure 10: Percent survival against 42 day exposure (1) and (2) for 10ng EE2/L treatment groups of 







Figure 11: Percent survival against 42 day exposure (1) and (2) for 100ng EE2/L treatment groups of 







Figure 12: Percent survival against 42 day exposure (1) and (2) for 250ng EE2/L treatment groups of 



























A c u t e  e x p o s u r e  ( 2 ) :  f e m a l e  p r o p o r t i o n













M e O H  c o n t r o l
 1 0 n g  E E 2 / L
 




BETWEEN RUN PRECISION & ACCURACY 
ng/L  ng/L 
 
% % differ 
nominal mean calc SD RSD accuracy 
1.0 1.0 0.2 19.0% 105% 
2.5 2.0 0.3 14.3% 81% 
10.0 11.6 1.9 16.1% 116% 
50.0 49.3 8.2 16.5% 99% 
100.0 97.2 17.0 17.4% 97% 
250.0 248.7 22.9 9.2% 99% 
WITHIN RUN PRECISION & ACCURACY 
ng/L  ng/L 
 
% % differ 
nominal mean calc SD RSD accuracy 
1.0 1.1 0.1 8.0% 109% 
2.5 2.3 0.3 11.8% 92% 
10.0 9.6 0.8 8.3% 96% 
50.0 47.3 2.5 5.2% 95% 
100.0 111.2 6.7 6.0% 111% 
250.0 242.0 18.0 7.4% 97% 







mean SD RSD 
 250ng/L  228.983 134.9086 58.9% n=5 
100ng/L 122.164 18.55928 15.2% n=4 
10ng/L  15.580 9.510547 61.0% n=5 
Table 4: Calculated mean concentrations of EE2 in mixing tank samples from acute exposure (2). 
 
 
Figure 14: Gel verification examples showing samples post-sonication to ensure target fragment size of 




Figure 15: Bioanalyzer results during quality control check of post-sonication and post-AMPure 




Table 5: Average sequence coverage for acute exposure (2) 
per maternal sample 











































96294 8-3abM6 94090 8-3ab10.6 95028 
 
Table 7: Average sequence coverage for acute exposure 
(2) Tu pair 
Sample ID coverage Sample ID coverage 
7-3tuM1 92037 7-3tu10-1 94186 
7-3tuM2 90003 7-3tu10-2 94150 
7-3tuM3 94058 7-3tu10-3 93702 
7-3tuM4 88071 7-3tu10-4 74148 
7-3tuM5 92173 7-3tu10-5 88435 


























































































Table 9: Average sequence coverage for baseline fish 
Sample ID coverage Sample ID coverage Sample ID coverage 
ab1f 94627 tu1f 91613 wik1f 94509 
ab2f 76843 tu2f 89338 wik2f 94233 
ab3f 81699 tu3f 91462 wik3f 96490 
ab4f 91078 tu4f 90188 wik4f 92016 
ab5f 95675 tu5f 87682 wik5f 97850 
ab1m 91327 tu1m 80310 wik1m 79232 
ab2m 73759 tu2m 82806 wik2m 68031 
ab3m 84021 tu3m 89455 wik3m 79096 
ab4m 81127 tu4m 39080 wik4m 90175 





Figure 16: Replicates overlaid sequence coverage to demonstrate general trend of coverage across 
mtgenome. Each sample is associated strain color (AB-green, Tu-blue, WIK-orange) with grey for 




Table 10: Alignment scores for AB acute exposure sequencing samples 










1-1abM1 9785469 97.15% 1-1ab10-1 18649660 98.35% 
1-1abM2 10307998 97.55% 1-1ab10-2 10046209 92.18% 
1-1abM3 14540774 97.30% 1-1ab10-3 8392656 97.60% 
1-1abM4 9227333 78.14% 1-1ab10-4 12932520 98.31% 
1-1abM5 7497260 96.41% 1-1ab10-5 12384164 82.28% 
1-1abM6 15135670 98.24% 1-1ab10-6 13416254 95.35% 
8-3abM1 10327609 96.64% 8-3ab10-2 9041167 88.27% 
8-3abM2 15593195 98.10% 8-3ab10-2 10849477 77.96% 
8-3abM3 12370702 98.55% 8-3ab10-3 46985325 98.37% 
8-3abM4 12545758 96.91% 8-3ab10-4 48892407 96.54% 
8-3abM5 12833063 96.59% 8-3ab10-5 46088237 95.95% 
8-3abM6 11075324 97.53% 8-3ab10-6 25023956 94.49% 















Table 11: Alignment scores for Tu acute exposure sequencing samples 










7-3tuM1 9996541 96.22% 7-3tu10-1 12202077 96.38% 
7-3tuM2 9380990 95.24% 7-3tu10-2 10783675 95.32% 
7-3tuM3 12103602 97.89% 7-3tu10-3 9709533 96.51% 
7-3tuM4 8837643 88.90% 7-3tu10-4 12448650 76.17% 
7-3tuM5 9372289 96.82% 7-3tu10-5 13161170 94.65% 
7-3tuM6 9195572 97.59% 7-3tu10-6 10863646 96.79% 
7-3tuM2 - 
REP 
13484344 95.12% 7-3tu10-1-REP 14157961 96.52% 
































1-1wikM1 11483722 97.65% 1-1wik10-1 17343530 94.73% 
1-1wikM2 13647048 95.32% 1-1wik10-2 22664699 97.95% 
1-1wikM3 13007021 97.52% 1-1wik10-3 15159812 98.46% 
1-1wikM4 12026852 87.34% 1-1wik10-4 13131655 96.35% 
1-1wikM5 8499963 96.97% 1-1wik10-5 12758576 91.01% 
1-1wikM6 11600664 95.40% 1-1wik10-6 15418596 97.06% 
1-2wikM1 12591621 96.75% 1-2wik10-1 13475882 97.80% 
1-2wikM2 13081604 96.62% 1-2wik10-2 13582151 92.57% 
1-2wikM3 8791778 97.74% 1-2wik10-3 9741137 91.16% 
1-2wikM4 10431192 98.10% 1-2wik10-4 11695032 97.43% 
1-2wikM5 9229908 96.36% 1-2wik10-5 10221356 97.70% 
1-2wikM6 13149401 97.70% 1-2wik10-6 13164686 97.80% 
   1-2wik10-3-REP 8390810 96.71% 






































ab1f 11997623 96.33 tu1f 9770625 98.05 wik1f 17152404 97.46 
ab2f 6748448 97.09 tu2f 10730290 97.96 wik2f 12065535 97.10 
ab3f 8431181 98.28 tu3f 10937490 98.52 wik3f 25447115 98.85 
ab4f 9358941 93.32 tu4f 10048129 97.68 wik4f 9592859 96.45 
ab5f 48378428 98.58 tu5f 9698742 96.10 wik5f 75301641 98.49 
ab1m 9919322 97.73 tu1m 8152350 98.02 wik1m 8304676 94.49 
ab2m 7485225 96.14 tu2m 7482459 96.16 wik2m 6844795 94.96 
ab3m 8713971 94.45 tu3m 11928427 97.86 wik3m 9489164 97.16 
ab4m 10804879 70.17 tu4m 30001454 97.96 wik4m 12682535 97.71 
ab5m 14160408 97.09 tu5m 11999388 97.16 wik5m 14932480 97.24 
ab4m-
REP 7444162 96.18 
      ab4f-
REP 7936482 98.00 
      














Table 14: Alignment scores for maternal sequencing samples 
Maternal ID Total reads 
Percent aligned to 
mtgenome 
1-1abf 8049851 94.12% 
8-3abf 7722668 93.41% 
2-1tuf n/a n/a 
7-3tuf 10166509 97.65% 
1-1wikf   
1-2wikf 9261831 97.03% 
















Figure 17: Linear regression of sequencing replicate heteroplasmy representing each strain (AB, Tu, 
and WIK), same vs different sequencing lanes between replicates, and differing groups (baseline, 




Table 15: Comparison of replicate samples sequencing design and values 
Lane design Group 
Replicate Sample 
ID 
Average error Greatest error 
Same lane 
Control 7-3tuM2 0.000069 0.0096 
Treated 7-3tu10-1 0.000104 0.029 
Different lane 
Treated 1-2wik10-3 0.000147 0.076 
Baseline ab4f 0.000102 0.00037 
Baseline ab4m 0.000121 0.0079 
 
Table 16: Top ten sites on mtgenome with greatest heteroplasmic variance between 
replicates 
Site 7-3tuM2 7-3tu10-1 1-2wik10-3 ab4f ab4m 
1 850 824 10535 834 834 
2 848 828 878 841 878 
3 834 825 870 843 804 
4 870 827 834 836 870 
5 827 837 13274 878 813 
6 825 833 6265 844 13202 
7 828 839 6176 908 855 
8 878 834 11293 825 4399 
9 824 846 11134 804 896 
10 839 843 5676 828 843 
Top ten sites on mtgenome with greatest rate of heteroplasmic variance between replicate samples. 
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Figure 18: Breakdown of heteroplasmic sites ≥0.075% per individual of baseline fish, strains AB 
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Figure 19: Breakdown of heteroplasmic sites ≥0.075% in baseline fish, strains AB (green), Tu (blue) 
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Figure 20: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng 
EE2/L treated fish of two different AB pairs (1-1 left and 8-3 right). 
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Figure 21: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng 
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Figure 22: Breakdown of heteroplasmic sites ≥0.075% in maternal, MeOH control fish and 10ng 
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Figure 23: Breakdown of heteroplasmic sites ≥0.075% in maternal fish by pair and strain (AB pairs in 
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Figure 24: Breakdown of heteroplasmic sites ≥0.075% in control (no pattern) vs EE2 treated fish 
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Figure 25: Breakdown of heteroplasmic sites ≥0.075% in MeOH control vs 10ng EE2/L treated fish 
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Figure 26: Breakdown of heteroplasmic sites ≥0.075% in each pooled group: MeOH control, 10ng 




Chapter IV: Chronic treatment study 
Introduction 
 Environmental estrogens are a potent class of toxicants found ubiquitously in our 
environment as a result of their wide range of uses in commercial and industrial products 
including  pesticides, plastics, and pharmaceuticals (Fenske et al., 2005; Ropero et al., 
2006). Environmental estrogens present a significant health concern as numerous studies 
have demonstrated synthetic estrogens modulate and/or disrupt a variety of animal 
systems (Hecker & Hollert, 2011). Such studies demonstrating physiological and 
developmental dysfunction on both aquatic and terrestrial vertebrate species within 
environmentally relevant concentrations include: reduced sperm production, altered 
spermantogenesis, intersex and complete feminization of males, altered female oogenesis 
and induction of aneuploidy in both sexes (Brown et al., 2008; Hunt et al., 2003; Kidd et 
al., 2007; Schultz et al., 2003; Takahashi & Oishi, 2006; Tyler & Jobling, 2008).  
 Despite it being widely accepted environmental estrogen exposure has the ability 
to interfere with a variety of vertebrate organ system, the extent of these effects are 
continually being investigated. Of these, the investigation of mitochondria as targets of 
toxicant exposure is of great concern as these organelles are responsible for cellular life-
death decisions and also play critical roles in many other physiological processes (Cheng 
& Ristow, 2013). With specific concern for mtgenome susceptibility from environmental 
estrogen exposure, we aimed to continue our investigation on the effects of 17α-
ethynylestradiol (EE2) exposure on mitochondrial genome stability. 
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 The objective of this study was to further investigate the effects of chronic 
exposure to the common environmental estrogen EE2 on mitochondrial DNA (mtDNA) 
stability in zebrafish from embryonic development through reproductive maturity. The 
current challenge of sequencing studies is often dependent on project funding. 
Unfortunately, financial constraints limited this study from being carried through 
completion of DNA sequencing and analysis; however, concerning effects of the test 
compound on common fish development, life cycle and sex determination were observed.  
Methods 
 All fish were maintained in accordance to guidelines established by the 
Institutional Animal Care and Use Committee (IACUC) of Portland State University. 
Adult male and female zebrafish for generation of embryos used in chronic exposure, of 
the three common laboratory strains AB, Tu, and WIK, less than one year of age were 
obtained from the Zebrafish International Resource Center (ZIRC). Fish were housed in 
2.8-liter baffled flow-through tanks at a ratio of 1 male: 1 female with a stocking density 
of 10 or less fish per 2.8L tank in the Brown Zebrafish Aquatics Facility at Portland State 
University.  
 Fish were maintained on the Aquaneering Modular System with 4-stage central 
filtration providing continuous flow-through of recirculating water with a twice daily 
automated 10% water change. This system monitors parameters to stay within a narrow 
range. Aquatic facility had a photo period of 15h light: 9 hr dark. Fish were fed two times 
a day ad libitum with manufactured larvae power and live Artemia salina (brine shrimp). 
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 Sexually mature zebrafish ~1 year of age were set up as breeding pairs (1 male:1 
female) in Aquaneering Crossing Tanks with dividers to separate each pair. The following 
morning, dividers were removed and zebrafish were allowed to spawn for up to 5 hours. 
Spawning occurred within the aquatic facility using system water. 
 The test compound 17α-ethynylestradiol (EE2) was obtained from Sigma-Aldrich  
(≥ 98% grade). EE2 was solubilized in 100% methanol at a ratio of 1mg/1mL. A final 
working concentration of 1ng EE2/µL in 10% methanol was prepared as the final 
exposure working stock for spiking treatment water. Control fish were exposed to 
methanol at the highest EE2 treatment concentration, 5µL 100% methanol/liter tank 
water or ≤0.0005%. 
 1-L amber glass bottles were filled with embryo media and spiked with EE2 
working stock at respective treatment concentration 24-hours prior treatment start. 
Embryos were collected within 6 hours of morning divider removal and rinsed with 
untreated embryo media (Cold Harbor Springs 60x recipe). At a stocking density of ≤50 
embryos per petri dish, embryos were submersed in pre-mixed treatment water from one 
of five treatment groups: control, 1, 10, 25 or 50ng EE2/L. Petri dishes were placed in an 
incubator at 28°C for 5 days. Non-viable embryos were pulled and counts were recorded 
daily along with 2 water changes within the first five days post fertilization (dpf).  
 At 5 dpf, hatched larvae were transferred to 600mL glass beakers in pre-mixed 
respective exposure water and started on concentrated rotifers twice daily ad libitum. Full 
sib, same strain, grouped larvae were housed in 600mL beakers until 6 weeks of age with 
water changes every other day of pre-mixed exposure water. At 9dpf larvae were 
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transitioned to live brine shrimp in addition to rotifers. Larval powder was introduced at 
14 dpf. Fish were transitioned to powder only at 3 weeks and raised under these 
conditions until 6 weeks of age.  
 The exposure system used was as described in chapter III methods, acute 
exposure design. At six weeks of age, 20 full-sibs of each pair/strain/treatment were 
transferred to exposure system 1 gallon fish bowls. Common 20-gallon mixing tanks for 
respective treatments were filled and spiked with EE2 24-hours prior to transfer. 
Exposure to all fish at 50ng EE2/L was terminated after 6 weeks due abnormal growth 
patterns and impaired development. The remaining treatment groups: control, 1, 10, and 
25ng EE2/L were continued until 6 months of age. 
 Fish were housed on the exposure system until 6 months of age. 30-second 
flushes refreshed water every other day. Waste debris was removed via turkey baster. Fish 
were maintained on a standard adult feeding schedule using fish powder ad libitum, twice 
daily.  
 At the 6 week transfer only 20 fish per strain/pair/treatment were continued 
through the 6 month exposure. Remaining fish were raised in 600mL beaker conditions 
until 8 weeks of age for histological examination of gonadal tissue. At 8 weeks of age, 
juvenile larvae were euthanized in MS-222 (Sigma-Aldrich) at 300mg/L water at pH 8 
for ≥15 minutes after fasting for 24 hours. Fish were transferred to 10% neutral buffered 
formalin (Sigma-Aldridge) for ≥24 hours for fixation. Fixed fish were washed in 70% 
ethanol and transferred to embedding cassettes stored in 70% ethanol for further 
processing. Samples were sent to the Oregon Health and Science University, 
69 
 
Histopathology Shared Resource Center where fish were paraffin embedded, sectioned 
onto slides using mid-sagittal cuts and H&E stained.  
 After 6 months of exposure, fish were euthanized using MS-222 at a 
concentration of 300mg/L water at pH 8 for ≥15 minutes. Weight and sex was recorded 
prior to liver excision. Liver tissue was collected from zebrafish by surgical manipulation 
under a stereoscopic microscope (Leica Microsystems) and stored at -20°C for further 
use. 
 Exposure water samples (100mL) were collected monthly throughout exposures. 
Control water samples (100mL) were collected at the start, half-way and final month time 
points. Both exposure and control samples were immediately spiked with two internal 
standards (10ng/L). Samples were stored at 4°C until further analysis. 
 The following compounds were used for LC-MS evaluation: 17α-ethynylestradiol 
(EE2) was obtained from Sigma-Aldrich. Formic acid, methanol (LC-MS grade) and 
water (LC–MS grade) were from Burdick and Jackson (Muskegon, MI). 17β-Estradiol-
16, 16, 17-d3 (E2D3) was from Toronto Research Chemicals Inc. 17α-Ethynylestradiol-
2,4,16,16-d4 (EE2D4) was from CDN Isotopes. 
 Calibrators were generated to cover the concentration range of EE2 in mixing 
tank water from 0.1ng-100ng EE2/L using dilutions of authentic standard dried and 
derivatized using 1:1 100µl dansyl chloride in acetone and 100µl sodium bicarbonate 
incubated at 60°C for 4 mins, cooled to room temperature as starting mobile phase. 
 LC–ESI-MS analyses were performed using a high-resolution (30,000) Thermo 
LTQ-Orbitrap Discovery hybrid mass spectrometry instrument (San Jose, CA) equipped 
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with an electrospray ionization source operating in the positive mode. The ESI interface 
using the following settings: sheath gas flow rate 40 (arbitrary units), aux gas flow rate 15 
(arbitrary units), spray voltage 2kV, capillary temperature 250C, capillary voltage -17 V, 
and tube lens voltage -85 V. The Orbitrap was externally calibrated prior to data 
acquisition allowing accurate mass measurements for [M+H]+ or [M-H]- ions to be 
obtained to within 4ppm. 
 The Orbitrap was coupled to a Thermo Accela HPLC system. EE2 was resolved 
using a Kinetex C18 (4.6x50mm, 2.1 mm i.d., 2.5uL particle size) HPLC column with 
guard cartridge (Phenomenex; Torrance, CA). Mobile phases consisted of 0.1% formic 
acid in HPLC grade water (A), 0.1% formic acid in acetonitrile (CAN) (B). The gradient 
mobile phase was delivered at a flow rate of 0.3 mL/min and the formic:water mobile 
phase.  
 Start conditions were 30% B, increased to 98% B over 7 minutes, decreased to 
30% B over the next 2.5 minutes, 100% B over the next three minutes. Column was 
washed at 100% B for 1 minute and back to 30% B for 5 minutes. The column 
temperature was kept at 50°C using a thermostatic column oven. The sample injection 
volume was 20 μL. 
Results and Discussion 
 We exposed 6 groups of full-sib offspring from 3 strains of zebrafish: AB, Tu, and 
WIK, across 5 treatment categories: 1ng, 10ng, 25ng, 50ng EE2/L and control (methanol 
≤0.0005%) to assess the effects throughout development and maturation, embryos to 6 
months. Survival curves and sex ratios were examined after 6 month exposure. At 8 
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weeks of age, a portion of juveniles were partitioned off to examine the gonadal tissue 
after exposure from fertilization through sexual differentiation.  
 We were interested in comparing the survivorship of each treatment type (1ng, 
10ng, 25ng, and 50ng EE2/L) to control (≤0.0005% methanol) using three zebrafish 
strains (AB, Tu and WIK) from fertilization through 6 week exposure then continued 
from 6 weeks to 6 month exposure.  
 Survivorship from fertilization through 6 weeks of exposure are shown for all 
treatment types: control, 1ng, 10ng, 25ng, and 50ng EE2/L (figure 27); however, the 50ng 
EE2/L treated fish for all strains and pairs had impaired growth with survival lower than 
80% in 4 of 6 groups (pair/strain combo). Therefore the 50ng EE/L treatment was 
terminated at 8 weeks for all strain/pair combos as fish to prevent pain and suffering of 
surviving fish. In general the surviving fish did not appear healthy and exhibited (put 
abnormal traits observed here).  
 In all treatment groups, unaccounted loss (i.e., missed counts on tiny larvae and/or 
cannibalism) were shown on the last day of exposure. The greatest loss in all treatments 
occurred within the first 10 days post fertilization which is attributed to normal larval 
mortality. Control fish from 0-6 weeks had varied survival; however after 10 days post 
fertilization, the most fragile period of development, no strain/pair combo had greater 
than 10% loss over multiple day periods and loss beyond that was accounted for at the 
end of the 6 weeks. Similar patterns occurred from 0-6 weeks in 1ng, 10ng and 25ng 
EE2/L treatment groups; most loss occurring within the first 10 days and other major 
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losses shown at the end of the 6 week survivorship attributed to miscounts and/or 
cannibalism. 
 For the 6 week-6 month survival curves, 20 fish per tank were added and we 
therefore reset the percentage to 100%. Survival during this period was consistent across 
all tanks and strains (Figures 27-31). As in the 0-6wks survival curves, any miscounts are 
demonstrated at the end of the 180 day exposure which was <10% across all treatments. 
Among all strains and treatments a near  100% survival was observed. The exception to 
this was the 25ng EE2/L treated fish which exhibited between 70-90% survival in all 
strain/pair combos except 1, TuCH1. Phenotypically, 25ng EE2/L fish appeared to have 
similar appearance to other treatments despite survival patterns not demonstrating a 
similar pattern.  
 Among the 50 ng EE2/L treatments, the greatest loss occurred weeks 6 and 7. No 
outstanding differences were observed between strains, but the 50 ng EE2/L treated fish 
were not developing normally so treatments were terminated despite the absence of major 
losses to prevent undue pain and suffering. The greatest losses in the full exposure 
treatments from 6wks-6months occurred in the 25ng EE2/L despite no outwardly 
apparent developmental abnormalities and normal growth.  
 When evaluating the sex ratios among the surviving treatments, a trend was 
observed. The proportion of females increased along with treatment level (i.e., 1ng, 10ng, 
and 25ng EE2/L) compared to control (Figure 32). These differences resulted in a 
statistically significant difference in the proportion of females between control and 10ng 
EE2/L treated and control and 25ng EE2/L treated.  
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 Gross images were taken prior to fixation for histological processing to 
demonstrate morphological differences seen between control and treatment groups 
(Figures 33-36). Assessing three phenotypic categories, reduced body size, edema in 
body cavity and bulging eye (as seen in highest acute exposure treatment groups), we see 
that the 25ng and 50ng EE2/L treatment groups display abnormal growth patterns 
compared to control, 1ng and 10ng EE2/L treatments (Table 17) which is supported by 
our survival curves. 
 During processing, chemical resistant marker was used for labeling of cassettes; 
however, xylene used during processing resulted in loss of sample identification. No 
results can be reported on the whole fish mid-sagittal sections; however the slides were 
still assessed and general unique characteristics were seen. We observed distinct 
differences between slides including intersex gonadal tissue (Figure 38). In addition, we 
observed differential H&E staining uptake demonstrated in male liver tissue between 
males exposed to estrogen vs unexposed (Ven et al., 2003). We observed similar 
proportions of male liver tissue with basophilia as EE2 treated proportions sent for 
histological processing.  
 Analysis of samples showed contamination which was sourced to be within the 
100% methanol used for LC-MS specific solubilization. Samples could not be used for 
further analysis because this was the methanol stock used to prepare LC-MS EE2 and 
internal standard stocks; however, this was not the methanol used to prepare working 
EE2 stocks for spiking common mixing tanks. Despite contamination, we did find the 
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dansyl chloride derivatization method to be much more effective in increasing sensitivity 
to EE2 quantification.  
 As a result of funding, we were unable to carry samples through library 
preparation and sequencing as described in chapter II; however, samples are being stored 
at -20°C for future evaluation of the effects of chronic EE2 treatment from embryonic 
development through 6 months of age. We observed treatment specific effects despite not 
being able to analysis chronic treatment of EE2 on mitochondrial genome stability. 
 While we were not able to carry this study through its goal of examining the 
effects of chronic exposure of environmentally relevant concentrations of EE2 on three 
common strains of zebrafish from embryonic development to reproductive maturity, we 
were still able to gain valuable information from the exposure series of 1, 10, 25, and 
50ng EE2/L compared to our controls. Our results demonstrated normal development and 
growth at 1, 10, and 25ng EE2/L while toxicity at 50ng EE2/L in developing zebrafish 
was observed. We observed different female proportions between control versus our two 
highest concentrations of EE2 treatment, 10ng and 25ng EE2/L. When these results are 
taken into consideration with our acute exposure results of survivorship and female 
proportions, it supports the necessity behind further investigation of EE2 treatments at 
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Figure 27: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months 
(bottom) for control groups of three zebrafish strains: AB (green), Tu (blue), and WIK (orange) from 





Figure 28: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months 
(bottom) for 1ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK 





Figure 29: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months 
(bottom) for 10ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK 





Figure 30: Percent survival against 6 month exposure in 0dpf-6weeks (top) and 6weeks-6months 
(bottom) for 25ng EE2/L treatment groups of three zebrafish strains: AB (green), Tu (blue), and WIK 





Figure 31: Percent survival against 6 month exposure in 0dpf-6weeks for 50ng EE2/L treatment groups 
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Figure 32: Proportion of females between control and 1ng, 10ng, and 25ng EE2/L treated fish after 








Figure 34: Gross images via stereoscopic microscope camera of 50ng EE2/L treated larva at 8 weeks 
demonstrating reduced body size and edema in body cavity.  
 
 






Figure 36: Gross image via stereoscopic microscope camera of 25ng EE2/L treated larva at 8 
weeks
 
Figure 37: Gross images via stereoscopic microscope camera of 50ng EE2/L treated larva at 8 weeks 






Table 17: Control vs treated at 8 weeks, phenotypic comparison of 3 developmental categories 
Phenotype Control 1ng EE2/L 10ng EE2/L 25ng EE2/L 50ng EE2/L 
Reduced body size No No No Yes Yes 
Edema in body cavity No No No No Yes 
Bulging eye No No No No Yes 
 
 
Figure 38: Histology image of intersex tissue from 8 week old (potentially EE2 exposed) fish larva 





Chapter V: Discussion 
 This project aimed to assess the effects of environmentally relevant 
concentrations of 17α-ethynylestradiol on mitochondrial genome stability in the model 
zebrafish. My central hypothesis was, “The environmental estrogen 17-α ethynylestradiol 
increases mitochondrial DNA heteroplasmy.” Our investigation for testing this hypothesis 
revealed novel aspects of mutation accumulation within trout and among three strains of 
zebrafish evaluated. We demonstrated in two of our experimental investigations that 
environmentally relevant, low level exposure to EE2 increases mitochondrial 
heteroplasmy in two different species of fish. In addition to seeing effects on the 
mtgenome, we saw that both acute and chronic exposure to EE2 had severe effects of 
development and survival on zebrafish.  
 Further evaluation of this sequencing data is necessary to differentiate 
nonfunctional consequences from functional consequences. Of these increased 
heteroplasmic sites, which are associated directly to the exposure and of these which have 
the potential to, or currently decrease, mitochondrial function? In addition, continued 
investigation of environmental estrogen exposure on mtgenome stability is necessary for 
understanding the effects of exposure as well as the possible initiation of human disease 
state from exposure. We demonstrated that there is an overall increase in mitochondrial 
heteroplasmy under environmentally relevant exposure regimes, but what are the 
impactions for human health? Ultimately, can this eventually induce mitochondrial 
disease states?  
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 The results of this investigation provide the framework for studies involving 
toxicant exposure and mitochondrial genome stability. In this study we investigated a 
single toxicant; however, both aquatic and terrestrial vertebrates, including humans are 
exposed to a wealth of toxicants that have the potential to induce subtle and slow 
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